Cognition Therapeutics Inc
NASDAQ:CGTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cognition Therapeutics Inc
NASDAQ:CGTX
|
US |
|
M
|
Meyar Co
SAU:9565
|
SA |
|
SCSK Corp
TSE:9719
|
JP |
|
S
|
Sercomm Corp
TWSE:5388
|
TW |
|
W
|
World Fuel Services Corp
XBER:WFK
|
US |
|
R
|
Remedy Entertainment Oyj
OMXH:REMEDY
|
FI |
|
Quectel Wireless Solutions Co Ltd
SSE:603236
|
CN |
|
Reconditioned Systems Inc
OTC:AMXX
|
US |
|
E
|
EFC (I) Ltd
BSE:512008
|
IN |
|
S
|
Shui-Mu International Co Ltd
TWSE:8443
|
TW |
Balance Sheet
Balance Sheet Decomposition
Cognition Therapeutics Inc
Cognition Therapeutics Inc
Balance Sheet
Cognition Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
3
|
5
|
55
|
42
|
30
|
25
|
37
|
|
| Cash Equivalents |
3
|
5
|
55
|
42
|
30
|
25
|
37
|
|
| Total Receivables |
4
|
1
|
2
|
4
|
1
|
3
|
10
|
|
| Other Current Assets |
0
|
1
|
2
|
2
|
3
|
2
|
1
|
|
| Total Current Assets |
7
|
7
|
59
|
48
|
34
|
30
|
48
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Total Assets |
7
N/A
|
7
-5%
|
59
+731%
|
50
-15%
|
35
-30%
|
30
-14%
|
48
+60%
|
|
| Liabilities | ||||||||
| Accounts Payable |
2
|
2
|
4
|
3
|
4
|
2
|
1
|
|
| Accrued Liabilities |
1
|
1
|
2
|
2
|
4
|
8
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
2
|
2
|
2
|
1
|
1
|
|
| Total Current Liabilities |
4
|
3
|
8
|
8
|
10
|
11
|
14
|
|
| Long-Term Debt |
7
|
13
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
4
|
0
|
2
|
1
|
0
|
0
|
|
| Total Liabilities |
13
N/A
|
20
+54%
|
8
-61%
|
10
+30%
|
11
+5%
|
11
+7%
|
14
+23%
|
|
| Equity | ||||||||
| Common Stock |
53
|
55
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
58
|
68
|
94
|
115
|
141
|
175
|
199
|
|
| Additional Paid In Capital |
0
|
0
|
145
|
156
|
166
|
194
|
233
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
13
-133%
|
51
N/A
|
40
-21%
|
24
-39%
|
19
-23%
|
34
+83%
|
|
| Total Liabilities & Equity |
7
N/A
|
7
-5%
|
59
+731%
|
50
-15%
|
35
-30%
|
30
-14%
|
48
+60%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
21
|
21
|
22
|
29
|
32
|
60
|
89
|
|